Biotechnology
The Biotechnology industry has a total of 641 stocks, with a combined market cap of $828.56 billion and total revenue of $97.84 billion.
Market Cap
828.56B
Revenue
97.84B
Profits
-44.74B
PE Ratio
n/a
Profit Margin
-45.73%
Dividend Yield
0.05%
640 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 118.03B | 0.57% | 763,498 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 57.84B | -0.07% | 456,339 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.28B | 0.65% | 431,154 | 2.35B |
| 4 | ARGX | argenx SE | 33.14B | -0.30% | 289,566 | 2.64B |
| 5 | ONC | BeOne Medicines Ltd. | 29.08B | 0.48% | 172,377 | 4.18B |
| 6 | BNTX | BioNTech SE | 27.09B | 1.61% | 613,691 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 20.45B | 0.50% | 1,196,376 | 2.26B |
| 8 | INSM | Insmed Incorporated | 18.58B | -0.45% | 1,762,028 | 381.03M |
| 9 | SMMT | Summit Therapeutics Inc. | 18.23B | 8.53% | 12,732,495 | - |
| 10 | INCY | Incyte Corporation | 13.25B | 0.41% | 1,272,580 | 4.41B |
| 11 | EXEL | Exelixis, Inc. | 12.59B | 4.18% | 6,040,427 | 2.30B |
| 12 | GMAB | Genmab A/S | 12.53B | -0.68% | 1,125,763 | 3.23B |
| 13 | MRNA | Moderna, Inc. | 11.79B | 0.69% | 6,973,095 | 3.18B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 11.03B | 0.58% | 1,376,086 | 2.95B |
| 15 | ASND | Ascendis Pharma A/S | 10.55B | 0.62% | 157,784 | 398.51M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 8.35B | 2.71% | 2,459,384 | 127.42M |
| 17 | VRNA | Verona Pharma plc | 8.34B | 1.61% | 436,104 | 118.54M |
| 18 | TECH | Bio-Techne Corporation | 8.33B | -0.08% | 842,924 | 1.21B |
| 19 | BPMC | Blueprint Medicines Corporation | 8.31B | 0.12% | 1,350,210 | 562.12M |
| 20 | CORT | Corcept Therapeutics Incorporated | 7.66B | 1.30% | 675,731 | 685.45M |
| 21 | ROIV | Roivant Sciences Ltd. | 7.47B | 0.18% | 3,307,145 | 29.05M |
| 22 | CAI | Caris Life Sciences, Inc. | 7.38B | -0.67% | 498,971 | 452.50M |
| 23 | RVMD | Revolution Medicines, Inc. | 7.05B | 1.83% | 1,106,510 | - |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 6.84B | -1.35% | 1,335,952 | 717.25M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 6.65B | 0.30% | 867,429 | 1.08B |
| 26 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.64B | -0.43% | 108,674 | 317.38M |
| 27 | JAZZ | Jazz Pharmaceuticals plc | 6.62B | -0.43% | 327,043 | 4.06B |
| 28 | LEGN | Legend Biotech Corporation | 6.57B | -0.75% | 603,943 | 728.30M |
| 29 | NUVL | Nuvalent, Inc. | 5.78B | -0.02% | 299,177 | - |
| 30 | TGTX | TG Therapeutics, Inc. | 5.36B | 1.18% | 681,323 | 386.39M |
| 31 | TLX | Telix Pharmaceuticals Limited | 5.33B | -2.61% | 31,812 | 484.69M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 5.21B | 1.47% | 245,783 | 432.16M |
| 33 | CRSP | CRISPR Therapeutics AG | 4.79B | 0.97% | 1,839,156 | 37.68M |
| 34 | SLNO | Soleno Therapeutics, Inc. | 4.37B | 0.51% | 330,094 | - |
| 35 | ADMA | ADMA Biologics, Inc. | 4.36B | 0.77% | 1,053,200 | 459.38M |
| 36 | PCVX | Vaxcyte, Inc. | 4.29B | -0.06% | 474,834 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 4.18B | -1.72% | 628,345 | 136.86M |
| 38 | CYTK | Cytokinetics, Incorporated | 4.14B | 0.87% | 1,301,026 | 19.22M |
| 39 | KRYS | Krystal Biotech, Inc. | 4.13B | 1.22% | 168,215 | 333.45M |
| 40 | AKRO | Akero Therapeutics, Inc. | 4.13B | -0.21% | 404,787 | - |
| 41 | ZLAB | Zai Lab Limited | 4.03B | 2.56% | 581,959 | 418.33M |
| 42 | MRUS | Merus N.V. | 4.01B | 0.92% | 222,441 | 54.73M |
| 43 | PTCT | PTC Therapeutics, Inc. | 3.89B | -0.16% | 307,039 | 1.77B |
| 44 | RARE | Ultragenyx Pharmaceutical Inc. | 3.77B | 1.14% | 685,202 | 590.69M |
| 45 | ACLX | Arcellx, Inc. | 3.70B | 1.24% | 166,177 | 76.81M |
| 46 | AAPG | Ascentage Pharma Group International | 3.62B | 7.53% | 22,451 | 134.35M |
| 47 | RNA | Avidity Biosciences, Inc. | 3.52B | -0.65% | 553,899 | 8.93M |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 3.51B | -1.37% | 916,896 | 996.28M |
| 49 | SRRK | Scholar Rock Holding Corporation | 3.42B | 1.24% | 481,947 | - |
| 50 | VKTX | Viking Therapeutics, Inc. | 3.17B | 1.70% | 2,383,436 | - |
| 51 | PTGX | Protagonist Therapeutics, Inc. | 3.16B | 0.71% | 339,456 | 207.80M |
| 52 | KYMR | Kymera Therapeutics, Inc. | 3.14B | 0.58% | 240,486 | 58.89M |
| 53 | MLTX | MoonLake Immunotherapeutics | 3.10B | 2.15% | 244,049 | - |
| 54 | MTSR | Metsera, Inc. | 3.09B | 2.04% | 589,706 | - |
| 55 | IMVT | Immunovant, Inc. | 2.90B | 0.83% | 511,863 | - |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.79B | 1.22% | 461,098 | 760.00K |
| 57 | APGE | Apogee Therapeutics, Inc. | 2.77B | 7.08% | 507,950 | - |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.62B | 0.05% | 687,257 | 534.65M |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 2.55B | -0.33% | 492,450 | 7.50M |
| 60 | MIRM | Mirum Pharmaceuticals, Inc. | 2.49B | 2.46% | 216,660 | 379.25M |
| 61 | IBRX | ImmunityBio, Inc. | 2.40B | 3.03% | 3,275,284 | 31.22M |
| 62 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.32B | -0.65% | 800,484 | 545.21M |
| 63 | APLS | Apellis Pharmaceuticals, Inc. | 2.29B | 2.47% | 891,077 | 775.84M |
| 64 | NAMS | NewAmsterdam Pharma Company N.V. | 2.23B | 4.69% | 666,606 | 47.14M |
| 65 | RXRX | Recursion Pharmaceuticals, Inc. | 2.14B | 1.15% | 16,581,539 | 59.79M |
| 66 | DNLI | Denali Therapeutics Inc. | 2.13B | -1.41% | 613,237 | - |
| 67 | VCEL | Vericel Corporation | 2.10B | 0.68% | 161,581 | 238.54M |
| 68 | AGIO | Agios Pharmaceuticals, Inc. | 2.09B | 2.04% | 258,682 | 37.04M |
| 69 | CGON | CG Oncology, Inc. | 2.05B | 0.82% | 349,427 | 662.00K |
| 70 | BEAM | Beam Therapeutics Inc. | 1.95B | 0.65% | 1,364,707 | 63.58M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 1.94B | 0.82% | 522,894 | 7.00M |
| 72 | BLTE | Belite Bio, Inc | 1.94B | 4.67% | 64,433 | - |
| 73 | GLPG | Galapagos NV | 1.90B | 0.98% | 147,602 | 311.49M |
| 74 | IRON | Disc Medicine, Inc. | 1.90B | 2.97% | 218,288 | - |
| 75 | CNTA | Centessa Pharmaceuticals plc | 1.88B | 2.40% | 689,124 | 15.00M |
| 76 | FOLD | Amicus Therapeutics, Inc. | 1.88B | 2.52% | 3,120,129 | 543.14M |
| 77 | HRMY | Harmony Biosciences Holdings, Inc. | 1.85B | 0.16% | 287,680 | 744.85M |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 1.79B | 2.79% | 1,018,529 | 189.53M |
| 79 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 0.22% | 2,484,358 | 2.23B |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 1.73B | 1.73% | 274,097 | 233.67M |
| 81 | IMCR | Immunocore Holdings plc | 1.66B | 0.82% | 121,185 | 333.58M |
| 82 | ARQT | Arcutis Biotherapeutics, Inc. | 1.65B | 0.44% | 778,148 | 212.82M |
| 83 | SPRY | ARS Pharmaceuticals, Inc. | 1.62B | -1.37% | 881,404 | 97.12M |
| 84 | OCUL | Ocular Therapeutix, Inc. | 1.53B | 1.69% | 1,158,707 | 59.65M |
| 85 | VERA | Vera Therapeutics, Inc. | 1.53B | 1.48% | 629,718 | - |
| 86 | BHVN | Biohaven Ltd. | 1.49B | -0.88% | 753,892 | - |
| 87 | ETNB | 89bio, Inc. | 1.48B | 0.59% | 1,940,335 | - |
| 88 | CLDX | Celldex Therapeutics, Inc. | 1.46B | -0.50% | 978,005 | 7.56M |
| 89 | JANX | Janux Therapeutics, Inc. | 1.45B | 1.62% | 302,406 | 9.34M |
| 90 | EWTX | Edgewise Therapeutics, Inc. | 1.37B | 0.15% | 361,182 | - |
| 91 | MESO | Mesoblast Limited | 1.36B | -1.66% | 208,806 | 5.67M |
| 92 | TVTX | Travere Therapeutics, Inc. | 1.33B | 1.15% | 663,447 | 273.53M |
| 93 | VRDN | Viridian Therapeutics, Inc. | 1.28B | 2.89% | 396,632 | 302.00K |
| 94 | DYN | Dyne Therapeutics, Inc. | 1.24B | -2.01% | 1,988,964 | - |
| 95 | CVAC | CureVac N.V. | 1.23B | 0.93% | 751,012 | 566.04M |
| 96 | ELVN | Enliven Therapeutics, Inc. | 1.22B | 0.44% | 272,507 | - |
| 97 | INVA | Innoviva, Inc. | 1.21B | -0.98% | 617,655 | 369.84M |
| 98 | GPCR | Structure Therapeutics Inc. | 1.17B | -0.37% | 372,489 | - |
| 99 | ABCL | AbCellera Biologics Inc. | 1.13B | 1.33% | 1,951,513 | 23.11M |
| 100 | NTLA | Intellia Therapeutics, Inc. | 1.11B | 0.09% | 2,810,385 | 45.57M |
| 101 | NVAX | Novavax, Inc. | 1.10B | 0.59% | 2,289,165 | 1.25B |
| 102 | MNKD | MannKind Corporation | 1.09B | -0.55% | 1,744,576 | 297.60M |
| 103 | CDTX | Cidara Therapeutics, Inc. | 1.08B | 1.90% | 412,642 | 302.00K |
| 104 | WVE | Wave Life Sciences Ltd. | 1.07B | 2.96% | 652,460 | 104.94M |
| 105 | LQDA | Liquidia Corporation | 1.04B | 1.08% | 1,028,158 | 14.14M |
| 106 | OCS | Oculis Holding AG | 1.04B | -0.84% | 8,545 | 847.33K |
| 107 | AUPH | Aurinia Pharmaceuticals Inc. | 1.03B | 1.34% | 1,011,325 | 247.30M |
| 108 | ARDX | Ardelyx, Inc. | 1.02B | 1.91% | 2,838,424 | 361.71M |
| 109 | PHVS | Pharvaris N.V. | 1.01B | 4.38% | 29,451 | - |
| 110 | VERV | Verve Therapeutics, Inc. | 1.01B | 0.62% | 1,140,860 | 59.61M |
| 111 | NAGE | Niagen Bioscience, Inc. | 1.00B | 1.03% | 726,910 | 107.93M |
| 112 | ZYME | Zymeworks Inc. | 975.97M | 1.16% | 285,469 | 93.38M |
| 113 | NRIX | Nurix Therapeutics, Inc. | 970.48M | 2.33% | 279,592 | 56.42M |
| 114 | PRAX | Praxis Precision Medicines, Inc. | 962.64M | 2.03% | 242,850 | 8.12M |
| 115 | SYRE | Spyre Therapeutics, Inc. | 951.17M | 1.68% | 506,667 | - |
| 116 | MLYS | Mineralys Therapeutics, Inc. | 947.65M | 1.68% | 349,891 | - |
| 117 | MDXG | MiMedx Group, Inc. | 936.43M | 1.77% | 319,254 | 352.38M |
| 118 | SION | Sionna Therapeutics, Inc. | 934.31M | 1.53% | 122,736 | - |
| 119 | GHRS | GH Research PLC | 925.15M | -0.77% | 100,034 | - |
| 120 | AVXL | Anavex Life Sciences Corp. | 921.16M | 2.08% | 800,367 | - |
| 121 | ORIC | ORIC Pharmaceuticals, Inc. | 920.42M | 1.41% | 348,770 | - |
| 122 | LENZ | LENZ Therapeutics, Inc. | 915.59M | 5.07% | 103,391 | - |
| 123 | GERN | Geron Corporation | 910.79M | 2.14% | 4,023,725 | 116.29M |
| 124 | RCUS | Arcus Biosciences, Inc. | 896.85M | -1.40% | 297,205 | 141.00M |
| 125 | CRMD | CorMedix Inc. | 864.87M | 0.26% | 1,079,174 | 82.55M |
| 126 | COGT | Cogent Biosciences, Inc. | 863.62M | 2.29% | 1,862,904 | - |
| 127 | QURE | uniQure N.V. | 789.47M | 0.98% | 328,120 | 20.20M |
| 128 | SNDX | Syndax Pharmaceuticals, Inc. | 774.43M | - | 817,805 | 43.72M |
| 129 | IMNM | Immunome, Inc. | 769.19M | 2.43% | 441,562 | 10.94M |
| 130 | XERS | Xeris Biopharma Holdings, Inc. | 760.74M | 0.42% | 1,081,665 | 222.55M |
| 131 | AVBP | ArriVent BioPharma, Inc. | 758.60M | -1.56% | 286,019 | - |
| 132 | VIR | Vir Biotechnology, Inc. | 747.87M | -0.37% | 395,502 | 20.86M |
| 133 | DNA | Ginkgo Bioworks Holdings, Inc. | 744.53M | 0.47% | 1,399,981 | 237.42M |
| 134 | GYRE | Gyre Therapeutics, Inc. | 737.04M | 4.23% | 66,023 | 100.64M |
| 135 | REPL | Replimune Group, Inc. | 724.62M | -1.57% | 581,092 | - |
| 136 | SANA | Sana Biotechnology, Inc. | 719.52M | 9.25% | 6,180,964 | - |
| 137 | PHAR | Pharming Group N.V. | 717.15M | -0.66% | - | 320.71M |
| 138 | NUVB | Nuvation Bio Inc. | 711.15M | 1.95% | 3,367,697 | 10.96M |
| 139 | TRVI | Trevi Therapeutics, Inc. | 708.91M | -0.50% | 993,025 | - |
| 140 | ANAB | AnaptysBio, Inc. | 697.79M | -0.54% | 211,537 | 111.87M |
| 141 | IMTX | Immatics N.V. | 694.05M | 2.15% | 174,163 | 155.80M |
| 142 | DAWN | Day One Biopharmaceuticals, Inc. | 689.26M | 1.04% | 445,420 | 161.92M |
| 143 | MRVI | Maravai LifeSciences Holdings, Inc. | 679.94M | 0.75% | 878,181 | 241.86M |
| 144 | EYPT | EyePoint Pharmaceuticals, Inc. | 668.85M | 0.62% | 332,551 | 56.04M |
| 145 | AUTL | Autolus Therapeutics plc | 630.76M | 0.85% | 451,118 | 9.01M |
| 146 | STOK | Stoke Therapeutics, Inc. | 626.77M | -0.61% | 185,736 | 190.91M |
| 147 | URGN | UroGen Pharma Ltd. | 626.14M | 4.78% | 737,303 | 91.87M |
| 148 | RLAY | Relay Therapeutics, Inc. | 622.35M | 0.83% | 536,585 | 7.68M |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 621.26M | 0.11% | 499,120 | 81.86M |
| 150 | ABUS | Arbutus Biopharma Corporation | 620.55M | 1.57% | 354,118 | 6.40M |
| 151 | TNGX | Tango Therapeutics, Inc. | 617.85M | 0.88% | 620,077 | 40.99M |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 606.22M | 2.56% | 101,602 | 6.52M |
| 153 | MGTX | MeiraGTx Holdings plc | 603.54M | 8.53% | 448,021 | 34.51M |
| 154 | UPB | Upstream Bio, Inc. | 602.49M | 0.63% | 212,087 | 2.30M |
| 155 | XNCR | Xencor, Inc. | 599.26M | 1.45% | 306,874 | 127.23M |
| 156 | KALV | KalVista Pharmaceuticals, Inc. | 595.59M | 1.70% | 338,525 | - |
| 157 | ATAI | Atai Life Sciences N.V. | 587.64M | 0.73% | 4,119,010 | 1.86M |
| 158 | IOVA | Iovance Biotherapeutics, Inc. | 584.39M | - | 4,636,003 | 212.68M |
| 159 | ARVN | Arvinas, Inc. | 580.28M | 0.63% | 826,658 | 426.90M |
| 160 | SAGE | Sage Therapeutics, Inc. | 576.12M | 1.32% | 3,011,704 | 47.40M |
| 161 | AMLX | Amylyx Pharmaceuticals, Inc. | 561.59M | -4.11% | 1,377,594 | -1.27M |
| 162 | TBPH | Theravance Biopharma, Inc. | 557.51M | 0.90% | 65,540 | 65.27M |
| 163 | KROS | Keros Therapeutics, Inc. | 546.28M | 0.30% | 147,998 | 214.71M |
| 164 | MNMD | Mind Medicine (MindMed) Inc. | 541.72M | 1.27% | 583,939 | - |
| 165 | ZVRA | Zevra Therapeutics, Inc. | 532.58M | 3.51% | 1,176,667 | 40.59M |
| 166 | TYRA | Tyra Biosciences, Inc. | 531.78M | -0.50% | 209,584 | - |
| 167 | TSHA | Taysha Gene Therapies, Inc. | 525.92M | 0.82% | 726,625 | 7.22M |
| 168 | CELC | Celcuity Inc. | 522.18M | 5.75% | 137,449 | - |
| 169 | BCYC | Bicycle Therapeutics plc | 514.56M | -0.13% | 146,498 | 25.72M |
| 170 | KURA | Kura Oncology, Inc. | 507.33M | 0.86% | 781,512 | 67.99M |
| 171 | SEPN | Septerna, Inc. | 506.63M | -0.26% | 187,930 | 977.00K |
| 172 | MAZE | Maze Therapeutics, Inc. | 503.67M | -3.04% | 78,145 | 167.50M |
| 173 | ABVX | ABIVAX Société Anonyme | 500.19M | 2.58% | 374,623 | 11.44M |
| 174 | BCAX | Bicara Therapeutics Inc. | 492.46M | -1.85% | 248,783 | - |
| 175 | PGEN | Precigen, Inc. | 478.19M | 0.62% | 608,700 | 4.20M |
| 176 | VALN | Valneva SE | 477.67M | - | 6,647 | 201.10M |
| 177 | FTRE | Fortrea Holdings Inc. | 472.62M | 0.97% | 837,626 | 2.69B |
| 178 | ATYR | aTyr Pharma, Inc. | 472.61M | 0.57% | 2,380,240 | 235.00K |
| 179 | ORKA | Oruka Therapeutics, Inc. | 471.75M | -0.08% | 148,945 | - |
| 180 | CAPR | Capricor Therapeutics, Inc. | 468.51M | 2.30% | 758,387 | 17.36M |
| 181 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
| 182 | SVRA | Savara Inc. | 461.41M | 4.29% | 1,104,500 | - |
| 183 | CGEM | Cullinan Therapeutics, Inc. | 460.90M | 0.64% | 146,711 | - |
| 184 | MREO | Mereo BioPharma Group plc | 456.33M | - | 799,148 | 1.00M |
| 185 | RGNX | REGENXBIO Inc. | 440.40M | 1.39% | 423,878 | 156.72M |
| 186 | RAPP | Rapport Therapeutics, Inc. | 439.43M | 2.03% | 60,888 | - |
| 187 | IVA | Inventiva S.A. | 434.40M | 1.01% | 7,112 | 14.59M |
| 188 | NKTR | Nektar Therapeutics | 428.37M | -3.02% | 994,109 | 87.25M |
| 189 | PRTC | PureTech Health plc | 424.55M | 4.65% | - | 4.83M |
| 190 | TRML | Tourmaline Bio, Inc. | 421.80M | 1.42% | 59,085 | - |
| 191 | ZBIO | Zenas BioPharma, Inc. | 419.60M | -1.86% | 145,704 | 15.00M |
| 192 | MBX | MBX Biosciences, Inc. | 416.80M | 1.14% | 92,284 | - |
| 193 | RZLT | Rezolute, Inc. | 412.20M | -0.82% | 612,521 | - |
| 194 | ERAS | Erasca, Inc. | 407.93M | -0.69% | 867,484 | - |
| 195 | PRME | Prime Medicine, Inc. | 407.48M | 1.30% | 3,704,342 | 3.85M |
| 196 | AURA | Aura Biosciences, Inc. | 406.75M | 1.55% | 127,517 | - |
| 197 | TECX | Tectonic Therapeutic, Inc. | 398.47M | 1.19% | 35,931 | - |
| 198 | CTMX | CytomX Therapeutics, Inc. | 393.86M | 0.81% | 755,657 | 147.56M |
| 199 | SLDB | Solid Biosciences Inc. | 389.90M | 3.29% | 702,297 | - |
| 200 | ITOS | iTeos Therapeutics, Inc. | 389.63M | 0.20% | 385,608 | 35.00M |
| 201 | ALT | Altimmune, Inc. | 386.07M | -2.86% | 6,331,550 | 20.00K |
| 202 | CMPX | Compass Therapeutics, Inc. | 384.43M | 6.11% | 804,511 | 850.00K |
| 203 | VIGL | Vigil Neuroscience, Inc. | 380.94M | 0.13% | 421,408 | - |
| 204 | TERN | Terns Pharmaceuticals, Inc. | 377.30M | 1.41% | 263,302 | - |
| 205 | ARCT | Arcturus Therapeutics Holdings Inc. | 373.72M | 1.17% | 172,649 | 143.68M |
| 206 | FULC | Fulcrum Therapeutics, Inc. | 373.54M | -0.14% | 146,358 | 80.00M |
| 207 | JBIO | Jade Biosciences, Inc. | 359.11M | 3.15% | 110,749 | - |
| 208 | HUMA | Humacyte, Inc. | 353.67M | -1.30% | 1,354,463 | 517.00K |
| 209 | ABSI | Absci Corporation | 353.34M | 2.97% | 2,711,520 | 4.82M |
| 210 | PRTA | Prothena Corporation plc | 346.38M | 1.82% | 636,675 | 137.94M |
| 211 | BNTC | Benitec Biopharma Inc. | 345.72M | 3.38% | 74,946 | - |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 338.33M | 1.50% | 97,440 | 203.08M |
| 213 | HRTX | Heron Therapeutics, Inc. | 335.64M | 2.33% | 823,587 | 148.52M |
| 214 | ATXS | Astria Therapeutics, Inc. | 327.88M | 1.40% | 188,854 | - |
| 215 | LXRX | Lexicon Pharmaceuticals, Inc. | 327.22M | -1.63% | 1,645,721 | 31.21M |
| 216 | XOMA | XOMA Royalty Corporation | 322.63M | 3.26% | 25,289 | 42.91M |
| 217 | AVIR | Atea Pharmaceuticals, Inc. | 320.07M | 3.17% | 286,643 | - |
| 218 | ANNX | Annexon, Inc. | 317.07M | 2.85% | 1,884,034 | - |
| 219 | OLMA | Olema Pharmaceuticals, Inc. | 312.69M | 0.66% | 210,209 | - |
| 220 | RCKT | Rocket Pharmaceuticals, Inc. | 312.44M | 0.69% | 1,748,943 | - |
| 221 | CRVS | Corvus Pharmaceuticals, Inc. | 304.60M | -0.75% | 313,953 | - |
| 222 | AARD | Aardvark Therapeutics, Inc. | 302.01M | 2.96% | 10,552 | - |
| 223 | ABEO | Abeona Therapeutics Inc. | 301.31M | 0.34% | 372,906 | - |
| 224 | GLUE | Monte Rosa Therapeutics, Inc. | 299.55M | 2.96% | 198,841 | 159.49M |
| 225 | VNDA | Vanda Pharmaceuticals Inc. | 292.90M | 1.64% | 293,730 | 201.35M |
| 226 | RNAC | Cartesian Therapeutics, Inc. | 290.95M | -1.41% | 52,347 | 34.17M |
| 227 | DBVT | DBV Technologies S.A. | 289.51M | 12.62% | 29,062 | 3.50M |
| 228 | NGNE | Neurogene Inc. | 286.52M | 1.72% | 75,528 | 925.00K |
| 229 | FHTX | Foghorn Therapeutics Inc. | 285.95M | 3.64% | 80,445 | 23.50M |
| 230 | ADCT | ADC Therapeutics SA | 282.66M | 1.79% | 323,648 | 75.82M |
| 231 | GOSS | Gossamer Bio, Inc. | 281.85M | 2.48% | 433,035 | 124.59M |
| 232 | OCGN | Ocugen, Inc. | 279.47M | 3.30% | 3,276,562 | 4.52M |
| 233 | DRTS | Alpha Tau Medical Ltd. | 268.50M | - | 21,921 | - |
| 234 | PVLA | Palvella Therapeutics, Inc. | 266.66M | 1.22% | 40,231 | - |
| 235 | SGMT | Sagimet Biosciences Inc. | 265.61M | 1.73% | 555,870 | - |
| 236 | VSTM | Verastem, Inc. | 263.76M | -1.03% | 1,674,821 | 10.00M |
| 237 | TNXP | Tonix Pharmaceuticals Holding Corp. | 262.76M | 0.88% | 277,119 | 10.04M |
| 238 | SLN | Silence Therapeutics plc | 260.71M | -2.99% | 26,178 | 27.70M |
| 239 | ALLO | Allogene Therapeutics, Inc. | 260.29M | -0.83% | 1,384,911 | 22.00K |
| 240 | ALDX | Aldeyra Therapeutics, Inc. | 257.55M | 7.50% | 757,049 | - |
| 241 | CADL | Candel Therapeutics, Inc. | 255.52M | 2.20% | 619,064 | - |
| 242 | TRDA | Entrada Therapeutics, Inc. | 254.91M | -0.55% | 66,445 | 172.22M |
| 243 | THRD | Third Harmonic Bio, Inc. | 245.04M | 0.18% | 37,814 | - |
| 244 | CRDF | Cardiff Oncology, Inc. | 243.48M | 1.95% | 635,008 | 587.00K |
| 245 | FENC | Fennec Pharmaceuticals Inc. | 243.04M | 3.04% | 80,313 | 30.91M |
| 246 | NBTX | Nanobiotix S.A. | 240.31M | 2.96% | 809 | -7.44M |
| 247 | LXEO | Lexeo Therapeutics, Inc. | 240.29M | 1.60% | 193,219 | - |
| 248 | IMMP | Immutep Limited | 239.91M | 1.18% | 16,488 | 3.02M |
| 249 | VOR | Vor Biopharma Inc. | 238.67M | 31.72% | 24,459,370 | - |
| 250 | CBIO | Crescent Biopharma, Inc. | 237.61M | 2.19% | 171,070 | - |
| 251 | INBX | Inhibrx Biosciences, Inc. | 236.39M | 3.75% | 53,380 | 200.00K |
| 252 | OABI | OmniAb, Inc. | 236.11M | 3.76% | 234,381 | 26.74M |
| 253 | LIMN | Liminatus Pharma, Inc. | 234.65M | 2.38% | 195,703 | - |
| 254 | LCTX | Lineage Cell Therapeutics, Inc. | 230.64M | -0.98% | 912,561 | 9.56M |
| 255 | TENX | Tenax Therapeutics, Inc. | 230.61M | 1.22% | 5,974 | - |
| 256 | PRQR | ProQR Therapeutics N.V. | 229.65M | 2.35% | 175,653 | 21.21M |
| 257 | CDXS | Codexis, Inc. | 229.48M | -1.42% | 1,467,715 | 49.82M |
| 258 | TVGN | Tevogen Bio Holdings Inc. | 228.71M | -0.80% | 142,244 | - |
| 259 | MNPR | Monopar Therapeutics Inc. | 221.68M | 3.10% | 24,004 | - |
| 260 | SLS | SELLAS Life Sciences Group, Inc. | 216.52M | 2.36% | 1,396,373 | - |
| 261 | EDIT | Editas Medicine, Inc. | 215.14M | 0.39% | 1,914,797 | 35.84M |
| 262 | DSGN | Design Therapeutics, Inc. | 214.02M | 2.45% | 47,533 | - |
| 263 | TVRD | Tvardi Therapeutics, Inc. | 210.25M | 4.71% | 19,658 | - |
| 264 | SCPH | scPharmaceuticals Inc. | 209.58M | -1.73% | 184,541 | 41.98M |
| 265 | MDWD | MediWound Ltd. | 209.02M | 1.15% | 10,184 | 19.21M |
| 266 | KOD | Kodiak Sciences Inc. | 207.89M | 3.13% | 311,528 | - |
| 267 | CRGX | CARGO Therapeutics, Inc. | 205.67M | 1.36% | 147,922 | - |
| 268 | LRMR | Larimar Therapeutics, Inc. | 204.89M | 2.89% | 515,980 | - |
| 269 | ACIU | AC Immune SA | 204.81M | 2.48% | 113,289 | 32.01M |
| 270 | FDMT | 4D Molecular Therapeutics, Inc. | 196.42M | -1.62% | 196,317 | 23.00K |
| 271 | EPRX | Eupraxia Pharmaceuticals Inc. | 195.28M | - | 8,647 | - |
| 272 | YMAB | Y-mAbs Therapeutics, Inc. | 194.77M | 0.94% | 81,293 | 88.66M |
| 273 | ENGN | enGene Holdings Inc. | 194.20M | 1.60% | 45,357 | - |
| 274 | ENGNW | enGene Holdings Inc. | 194.20M | - | - | - |
| 275 | GNFT | Genfit S.A. | 193.28M | -0.51% | - | 73.19M |
| 276 | OMER | Omeros Corporation | 187.50M | 3.56% | 536,660 | - |
| 277 | DRUG | Bright Minds Biosciences Inc. | 187.33M | 1.29% | 18,913 | - |
| 278 | PROK | ProKidney Corp. | 186.51M | 10.11% | 1,540,248 | 306.00K |
| 279 | ALMS | Alumis Inc. | 184.98M | 3.66% | 444,404 | 17.39M |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 184.44M | 0.65% | 194,685 | - |
| 281 | CYBN | Cybin Inc. | 182.88M | 7.59% | 442,098 | - |
| 282 | TIL | Instil Bio, Inc. | 180.40M | 15.50% | 596,512 | - |
| 283 | NVCT | Nuvectis Pharma, Inc. | 178.20M | 0.27% | 36,234 | - |
| 284 | PBYI | Puma Biotechnology, Inc. | 177.70M | 0.56% | 127,427 | 232.71M |
| 285 | VYGR | Voyager Therapeutics, Inc. | 177.08M | - | 303,242 | 66.96M |
| 286 | IMAB | I-Mab | 175.57M | -6.11% | 358,494 | 569.46K |
| 287 | ENTA | Enanta Pharmaceuticals, Inc. | 168.66M | -1.00% | 78,004 | 64.46M |
| 288 | TLSA | Tiziana Life Sciences Ltd | 168.31M | -3.82% | 179,781 | - |
| 289 | ACOG | Alpha Cognition Inc. | 167.65M | -2.10% | 55,837 | 2.93M |
| 290 | FBRX | Forte Biosciences, Inc. | 166.84M | -1.30% | 23,698 | - |
| 291 | AGEN | Agenus Inc. | 166.42M | 10.16% | 1,273,085 | 99.52M |
| 292 | IPHA | Innate Pharma S.A. | 165.19M | 3.02% | 489 | 20.83M |
| 293 | CGEN | Compugen Ltd. | 164.58M | 1.15% | 94,586 | 27.59M |
| 294 | SPRO | Spero Therapeutics, Inc. | 162.70M | 0.34% | 389,010 | 44.58M |
| 295 | DMAC | DiaMedica Therapeutics Inc. | 161.24M | 5.32% | 152,997 | - |
| 296 | ACRS | Aclaris Therapeutics, Inc. | 155.92M | -0.69% | 402,410 | 17.78M |
| 297 | ALEC | Alector, Inc. | 150.99M | 0.67% | 173,888 | 88.34M |
| 298 | VTYX | Ventyx Biosciences, Inc. | 148.02M | 2.97% | 873,557 | - |
| 299 | CUPR | Cuprina Holdings (Cayman) Limited | 148.01M | 3.29% | 432,197 | 35.41K |
| 300 | BDTX | Black Diamond Therapeutics, Inc. | 146.71M | -0.77% | 472,188 | 70.00M |
| 301 | CABA | Cabaletta Bio, Inc. | 146.61M | 1.87% | 930,391 | - |
| 302 | LYEL | Lyell Immunopharma, Inc. | 143.49M | 2.76% | 35,840 | 65.00K |
| 303 | THTX | Theratechnologies Inc. | 143.36M | 35.59% | 10,560,806 | 88.67M |
| 304 | SKYE | Skye Bioscience, Inc. | 142.84M | 10.55% | 947,853 | - |
| 305 | IKT | Inhibikase Therapeutics, Inc. | 140.51M | 2.16% | 81,965 | 1.00 |
| 306 | ASMB | Assembly Biosciences, Inc. | 138.55M | -0.87% | 15,693 | 32.15M |
| 307 | MOLN | Molecular Partners AG | 138.45M | 1.06% | 97 | 2.53M |
| 308 | GALT | Galectin Therapeutics Inc. | 137.98M | 0.46% | 239,497 | - |
| 309 | GLSI | Greenwich LifeSciences, Inc. | 134.08M | 1.52% | 31,419 | - |
| 310 | SEER | Seer, Inc. | 133.58M | 2.71% | 56,239 | 15.31M |
| 311 | RAPT | RAPT Therapeutics, Inc. | 133.12M | 0.50% | 19,411 | - |
| 312 | NMRA | Neumora Therapeutics, Inc. | 132.89M | 5.04% | 389,866 | - |
| 313 | ACTU | Actuate Therapeutics, Inc. | 129.29M | -2.23% | 53,961 | - |
| 314 | MIST | Milestone Pharmaceuticals Inc. | 128.77M | 1.04% | 237,741 | - |
| 315 | FATE | Fate Therapeutics, Inc. | 128.39M | - | 1,213,433 | 13.34M |
| 316 | CRBU | Caribou Biosciences, Inc. | 127.42M | - | 745,729 | 9.92M |
| 317 | ELTX | Elicio Therapeutics, Inc. | 126.42M | 0.76% | 15,069 | - |
| 318 | KRRO | Korro Bio, Inc. | 125.36M | 1.99% | 33,300 | 4.82M |
| 319 | SGMO | Sangamo Therapeutics, Inc. | 125.19M | -1.51% | 1,980,635 | 63.76M |
| 320 | NKTX | Nkarta, Inc. | 124.18M | 0.57% | 274,372 | - |
| 321 | IMRX | Immuneering Corporation | 124.15M | -3.90% | 908,523 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 122.59M | 2.67% | 409,479 | 59.76M |
| 323 | KYTX | Kyverna Therapeutics, Inc. | 121.45M | -0.53% | 537,924 | - |
| 324 | CLLS | Cellectis S.A. | 117.00M | -4.24% | 37,283 | 54.75M |
| 325 | HURA | TuHURA Biosciences, Inc. | 115.44M | -4.98% | 603,783 | - |
| 326 | ACHV | Achieve Life Sciences, Inc. | 112.16M | -3.54% | 817,651 | - |
| 327 | TARA | Protara Therapeutics, Inc. | 111.50M | 3.96% | 133,655 | - |
| 328 | GNLX | Genelux Corporation | 111.16M | 4.93% | 92,323 | 8.00K |
| 329 | NTHI | NeOnc Technologies Holdings, Inc. | 110.93M | 10.21% | 167,401 | 79.99K |
| 330 | OBIO | Orchestra BioMed Holdings, Inc. | 110.72M | 0.35% | 87,475 | 2.89M |
| 331 | NTRB | Nutriband Inc. | 110.30M | -7.56% | 180,708 | 2.40M |
| 332 | ATOS | Atossa Therapeutics, Inc. | 109.68M | 1.43% | 467,248 | - |
| 333 | VTVT | vTv Therapeutics Inc. | 107.98M | 0.07% | 2,082 | 17.00K |
| 334 | CSBR | Champions Oncology, Inc. | 105.27M | -1.16% | 11,533 | 58.59M |
| 335 | CCCC | C4 Therapeutics, Inc. | 105.09M | -2.63% | 727,672 | 39.78M |
| 336 | ANIX | Anixa Biosciences, Inc. | 104.04M | 1.25% | 38,111 | - |
| 337 | OKYO | OKYO Pharma Limited | 104.04M | -4.47% | 81,427 | - |
| 338 | MCRB | Seres Therapeutics, Inc. | 103.65M | 9.30% | 107,170 | - |
| 339 | NAUT | Nautilus Biotechnology, Inc. | 103.44M | 4.73% | 107,604 | - |
| 340 | HLVX | HilleVax, Inc. | 102.19M | -2.37% | 59,470 | - |
| 341 | JSPR | Jasper Therapeutics, Inc. | 101.70M | -0.73% | 336,840 | - |
| 342 | CTNM | Contineum Therapeutics, Inc. | 100.38M | -3.00% | 143,855 | - |
| 343 | COYA | Coya Therapeutics, Inc. | 99.68M | 3.11% | 72,648 | 3.69M |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 99.54M | -0.15% | 779,192 | - |
| 345 | IOBT | IO Biotech, Inc. | 98.16M | - | 182,872 | - |
| 346 | VXRT | Vaxart, Inc. | 97.45M | -2.51% | 1,619,231 | 47.40M |
| 347 | SAVA | Cassava Sciences, Inc. | 97.10M | - | 467,932 | - |
| 348 | XBIT | XBiotech Inc. | 96.95M | -1.24% | 28,527 | - |
| 349 | BMEA | Biomea Fusion, Inc. | 94.66M | 0.61% | 1,289,449 | - |
| 350 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 94.35M | -0.52% | 77,695 | - |
| 351 | CHRS | Coherus Oncology, Inc. | 93.91M | 1.87% | 679,404 | 272.25M |
| 352 | WHWK | Whitehawk Therapeutics, Inc. | 93.75M | 5.85% | 57,481 | 27.78M |
| 353 | MGNX | MacroGenics, Inc. | 92.11M | 5.80% | 699,979 | 154.05M |
| 354 | ZNTL | Zentalis Pharmaceuticals, Inc. | 90.66M | 1.61% | 384,919 | 26.87M |
| 355 | BYSI | BeyondSpring Inc. | 89.91M | -2.62% | 15,121 | 1.88M |
| 356 | ORMP | Oramed Pharmaceuticals Inc. | 89.05M | 0.93% | 18,025 | 2.00M |
| 357 | VERU | Veru Inc. | 88.92M | 3.94% | 897,828 | 16.89M |
| 358 | IVVD | Invivyd, Inc. | 88.18M | 1.67% | 527,935 | 36.69M |
| 359 | ADAG | Adagene Inc. | 87.15M | -4.64% | 16,381 | 103.20K |
| 360 | CLYM | Climb Bio, Inc. | 86.50M | 1.59% | 158,764 | - |
| 361 | ENTX | Entera Bio Ltd. | 85.91M | -1.04% | 17,961 | 223.00K |
| 362 | TCRX | TScan Therapeutics, Inc. | 85.45M | 2.72% | 185,958 | 4.42M |
| 363 | EXOZ | eXoZymes, Inc. | 82.92M | -2.84% | 1,206 | -700.00 |
| 364 | IGMS | IGM Biosciences, Inc. | 81.86M | 3.03% | 526,792 | 2.68M |
| 365 | ONCY | Oncolytics Biotech Inc. | 81.18M | 16.81% | 1,535,745 | - |
| 366 | GUTS | Fractyl Health, Inc. | 80.81M | 0.61% | 149,236 | 60.00K |
| 367 | ARMP | Armata Pharmaceuticals, Inc. | 78.54M | 11.86% | 43,768 | 4.70M |
| 368 | CBUS | Cibus, Inc. | 77.65M | 2.65% | 214,066 | 4.75M |
| 369 | PLRX | Pliant Therapeutics, Inc. | 77.35M | 5.00% | 1,120,940 | - |
| 370 | EPIX | ESSA Pharma Inc. | 77.24M | 2.35% | 48,109 | - |
| 371 | OTLK | Outlook Therapeutics, Inc. | 76.28M | 4.09% | 595,797 | - |
| 372 | VANI | Vivani Medical, Inc. | 74.65M | -0.79% | 44,350 | - |
| 373 | QNCX | Quince Therapeutics, Inc. | 73.20M | 0.63% | 138,721 | - |
| 374 | SRZN | Surrozen, Inc. | 71.58M | -4.35% | 22,879 | 11.64M |
| 375 | IMMX | Immix Biopharma, Inc. | 71.02M | 5.81% | 101,822 | - |
| 376 | ABOS | Acumen Pharmaceuticals, Inc. | 70.27M | 2.65% | 94,005 | - |
| 377 | ZURA | Zura Bio Limited | 69.92M | 0.89% | 129,512 | - |
| 378 | IMUX | Immunic, Inc. | 69.68M | 1.99% | 635,436 | - |
| 379 | GNTA | Genenta Science S.p.A. | 69.50M | -1.81% | 3,941 | - |
| 380 | ANEB | Anebulo Pharmaceuticals, Inc. | 69.02M | -7.18% | 10,666 | - |
| 381 | PYXS | Pyxis Oncology, Inc. | 68.14M | -8.33% | 503,969 | 16.15M |
| 382 | INO | Inovio Pharmaceuticals, Inc. | 67.78M | -37.85% | 21,094,785 | 283.10K |
| 383 | INMB | INmune Bio, Inc. | 67.26M | 7.20% | 4,695,992 | 50.00K |
| 384 | ADAP | Adaptimmune Therapeutics plc | 66.26M | 3.14% | 459,962 | 179.64M |
| 385 | VRCA | Verrica Pharmaceuticals Inc. | 65.36M | 9.01% | 484,479 | 7.18M |
| 386 | CNTB | Connect Biopharma Holdings Limited | 64.97M | 8.27% | 148,654 | 26.03M |
| 387 | STRO | Sutro Biopharma, Inc. | 64.46M | -0.10% | 141,879 | 66.43M |
| 388 | IKNA | Ikena Oncology, Inc. | 64.18M | 1.53% | 8,098 | - |
| 389 | ANRO | Alto Neuroscience, Inc. | 63.62M | 2.17% | 83,674 | - |
| 390 | CLSD | Clearside Biomedical, Inc. | 63.12M | 0.78% | 27,040 | 3.76M |
| 391 | MGX | Metagenomi, Inc. | 62.43M | 3.73% | 262,662 | 45.26M |
| 392 | PMVP | PMV Pharmaceuticals, Inc. | 61.82M | 8.18% | 582,828 | - |
| 393 | RPTX | Repare Therapeutics Inc. | 61.76M | - | 18,592 | 1.07M |
| 394 | MNOV | MediciNova, Inc. | 61.31M | -1.57% | 68,347 | - |
| 395 | PDSB | PDS Biotechnology Corporation | 60.79M | 4.72% | 141,434 | - |
| 396 | ATHE | Alterity Therapeutics Limited | 59.98M | 2.64% | 11,274 | 2.30M |
| 397 | IPA | ImmunoPrecise Antibodies Ltd. | 59.95M | 23.58% | 2,705,132 | 16.58M |
| 398 | IRD | Opus Genetics, Inc. | 59.66M | 1.01% | 186,001 | 13.65M |
| 399 | QNTM | Quantum BioPharma Ltd. | 59.29M | -10.96% | 329,739 | - |
| 400 | SER | Serina Therapeutics, Inc. | 59.21M | -3.26% | 1,152 | 51.00K |
| 401 | NRXP | NRx Pharmaceuticals, Inc. | 58.44M | 1.81% | 93,816 | - |
| 402 | VTGN | Vistagen Therapeutics, Inc. | 58.32M | -1.96% | 107,236 | 486.00K |
| 403 | UNCY | Unicycive Therapeutics, Inc. | 58.15M | -0.86% | 819,499 | - |
| 404 | ICCC | ImmuCell Corporation | 57.79M | 0.08% | 1,844 | 27.30M |
| 405 | CNTX | Context Therapeutics Inc. | 57.43M | 1.33% | 117,172 | - |
| 406 | SNTI | Senti Biosciences, Inc. | 57.38M | -0.45% | 113,763 | - |
| 407 | MAIA | MAIA Biotechnology, Inc. | 56.07M | -2.63% | 229,774 | - |
| 408 | FBIO | Fortress Biotech, Inc. | 55.59M | 2.73% | 180,983 | 57.78M |
| 409 | ANL | Adlai Nortye Ltd. | 55.35M | -1.12% | 272 | 1.94M |
| 410 | JUNS | Jupiter Neurosciences, Inc. | 54.62M | 38.66% | 4,934,400 | - |
| 411 | IFRX | InflaRx N.V. | 54.36M | -1.06% | 56,874 | 140.24K |
| 412 | OSTX | OS Therapies Incorporated | 54.30M | -4.19% | 8,014,762 | - |
| 413 | AVTX | Avalo Therapeutics, Inc. | 53.70M | 0.40% | 21,964 | 441.00K |
| 414 | CUE | Cue Biopharma, Inc. | 52.38M | 0.46% | 66,631 | 7.99M |
| 415 | ABVC | ABVC BioPharma, Inc. | 50.54M | 0.32% | 662,059 | 508.38K |
| 416 | ATRA | Atara Biotherapeutics, Inc. | 50.46M | 2.61% | 18,829 | 199.73M |
| 417 | ACET | Adicet Bio, Inc. | 50.20M | -1.14% | 545,900 | - |
| 418 | GANX | Gain Therapeutics, Inc. | 49.95M | 3.36% | 244,351 | - |
| 419 | RNXT | RenovoRx, Inc. | 49.74M | 4.62% | 93,331 | 240.00K |
| 420 | RENB | Renovaro Inc. | 49.73M | 3.44% | 622,484 | - |
| 421 | CRVO | CervoMed Inc. | 49.17M | 1.62% | 127,152 | 9.31M |
| 422 | DTIL | Precision BioSciences, Inc. | 48.12M | 1.88% | 61,283 | 51.14M |
| 423 | HOWL | Werewolf Therapeutics, Inc. | 48.01M | - | 146,942 | 1.14M |
| 424 | ALGS | Aligos Therapeutics, Inc. | 47.94M | 7.25% | 95,942 | 3.27M |
| 425 | IPSC | Century Therapeutics, Inc. | 47.83M | 0.02% | 214,227 | 114.90M |
| 426 | ADVM | Adverum Biotechnologies, Inc. | 47.63M | 0.88% | 73,585 | 1.00M |
| 427 | CELU | Celularity Inc. | 47.42M | -2.46% | 20,385 | 54.22M |
| 428 | KLRS | Kalaris Therapeutics, Inc. | 46.76M | -2.34% | 35,701 | - |
| 429 | ANVS | Annovis Bio, Inc. | 45.99M | -0.84% | 191,018 | - |
| 430 | NRSN | NeuroSense Therapeutics Ltd. | 45.82M | 0.53% | 85,947 | - |
| 431 | PLUR | Pluri Inc. | 45.51M | 7.26% | 17,215 | 1.03M |
| 432 | APLT | Applied Therapeutics, Inc. | 45.30M | -5.41% | 1,859,892 | 265.00K |
| 433 | ATNM | Actinium Pharmaceuticals, Inc. | 44.92M | 0.70% | 118,732 | 81.00K |
| 434 | PRLD | Prelude Therapeutics Incorporated | 44.82M | -0.76% | 87,143 | 7.00M |
| 435 | MURA | Mural Oncology plc | 44.55M | 2.79% | 127,240 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 43.28M | 3.64% | 28,550 | - |
| 437 | XCUR | Exicure, Inc. | 42.83M | 13.76% | 304,859 | 500.00K |
| 438 | ACRV | Acrivon Therapeutics, Inc. | 40.45M | - | 125,687 | - |
| 439 | STTK | Shattuck Labs, Inc. | 39.92M | -1.61% | 94,167 | 4.61M |
| 440 | PEPG | PepGen Inc. | 39.92M | 0.83% | 152,246 | - |
| 441 | ARTV | Artiva Biotherapeutics, Inc. | 39.22M | 1.26% | 78,135 | 251.00K |
| 442 | ITRM | Iterum Therapeutics plc | 38.56M | -0.42% | 491,861 | - |
| 443 | KPTI | Karyopharm Therapeutics Inc. | 37.93M | -4.77% | 36,005 | 142.13M |
| 444 | AKTX | Akari Therapeutics, Plc | 37.65M | 1.30% | - | - |
| 445 | BRNS | Barinthus Biotherapeutics plc | 37.16M | -2.63% | 16,172 | 14.97M |
| 446 | KLTO | Klotho Neurosciences, Inc. | 37.04M | -4.20% | 4,222,442 | - |
| 447 | XLO | Xilio Therapeutics, Inc. | 36.14M | 0.72% | 151,666 | 9.27M |
| 448 | MRSN | Mersana Therapeutics, Inc. | 36.08M | 3.50% | 1,856,247 | 34.01M |
| 449 | PYPD | PolyPid Ltd. | 35.67M | 0.29% | 82,445 | - |
| 450 | LTRN | Lantern Pharma Inc. | 35.05M | 2.20% | 22,338 | - |
| 451 | LVTX | LAVA Therapeutics N.V. | 34.72M | 0.76% | 3,996 | 4.99M |
| 452 | TELO | Telomir Pharmaceuticals, Inc. | 34.23M | -2.54% | 235,905 | - |
| 453 | RADX | Radiopharm Theranostics Limited | 34.19M | -2.05% | 59,760 | 204.61K |
| 454 | KZR | Kezar Life Sciences, Inc. | 33.46M | 2.00% | 22,529 | - |
| 455 | RNTX | Rein Therapeutics Inc. | 33.45M | -1.95% | 8,669 | - |
| 456 | KALA | KALA BIO, Inc. | 32.91M | 0.99% | 54,930 | - |
| 457 | OKUR | OnKure Therapeutics, Inc. | 32.15M | -0.83% | 38,849 | - |
| 458 | ESLA | Estrella Immunopharma, Inc. | 31.83M | -0.11% | 16,938 | - |
| 459 | ANTX | AN2 Therapeutics, Inc. | 31.68M | -2.78% | 66,614 | - |
| 460 | RANI | Rani Therapeutics Holdings, Inc. | 30.81M | 0.68% | 112,613 | 1.20M |
| 461 | TPST | Tempest Therapeutics, Inc. | 29.14M | - | 48,646 | - |
| 462 | CAMP | Camp4 Therapeutics Corporation | 28.82M | 5.93% | 51,353 | 1.51M |
| 463 | INKT | MiNK Therapeutics, Inc. | 28.82M | 0.86% | 3,359 | - |
| 464 | PASG | Passage Bio, Inc. | 28.66M | 13.51% | 499,654 | - |
| 465 | DYAI | Dyadic International, Inc. | 28.29M | - | 112,279 | 3.55M |
| 466 | ENLV | Enlivex Therapeutics Ltd. | 27.95M | 4.42% | 141,084 | - |
| 467 | PBM | Psyence Biomedical Ltd. | 27.81M | -7.88% | 28,644 | - |
| 468 | COEP | Coeptis Therapeutics Holdings, Inc. | 26.49M | 0.80% | 20,836 | 62.87K |
| 469 | OSRH | OSR Holdings, Inc. | 26.02M | -2.88% | 120,663 | -148.95K |
| 470 | CVKD | Cadrenal Therapeutics, Inc. | 25.53M | 4.34% | 20,178 | - |
| 471 | IGC | IGC Pharma, Inc. | 25.38M | -1.47% | 240,572 | 1.27M |
| 472 | GDTC | CytoMed Therapeutics Limited | 25.37M | 3.60% | - | 368.84K |
| 473 | CGTX | Cognition Therapeutics, Inc. | 25.15M | 20.82% | 14,393,104 | - |
| 474 | CTXR | Citius Pharmaceuticals, Inc. | 24.70M | 5.24% | 2,798,749 | - |
| 475 | ALXO | ALX Oncology Holdings Inc. | 24.59M | 3.39% | 235,511 | - |
| 476 | NRXS | NeurAxis, Inc. | 24.58M | 7.05% | 134,058 | 2.93M |
| 477 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 24.48M | -6.49% | 2,137,751 | - |
| 478 | MLEC | Moolec Science SA | 24.26M | 0.58% | 38,317 | 7.83M |
| 479 | OVID | Ovid Therapeutics Inc. | 24.06M | 2.39% | 276,234 | 548.00K |
| 480 | FBLG | FibroBiologics, Inc. | 24.02M | 0.29% | 366,945 | - |
| 481 | BOLD | Boundless Bio, Inc. | 23.95M | 0.94% | 56,070 | - |
| 482 | PULM | Pulmatrix, Inc. | 23.85M | -6.71% | 15,696 | 1.92M |
| 483 | VYNE | VYNE Therapeutics Inc. | 23.75M | -5.63% | 1,074,332 | 605.00K |
| 484 | GBIO | Generation Bio Co. | 22.99M | 1.51% | 676,550 | 24.56M |
| 485 | ELEV | Elevation Oncology, Inc. | 22.99M | 2.46% | 540,128 | - |
| 486 | FGEN | FibroGen, Inc. | 22.67M | 6.86% | 33,054 | 7.00M |
| 487 | LSTA | Lisata Therapeutics, Inc. | 22.53M | -4.03% | 16,914 | 1.00M |
| 488 | CALC | CalciMedica, Inc. | 22.49M | 1.90% | 21,507 | - |
| 489 | CMMB | Chemomab Therapeutics Ltd. | 22.23M | 0.87% | 39,709 | - |
| 490 | NNVC | NanoViricides, Inc. | 22.18M | -0.72% | 141,523 | - |
| 491 | BCAB | BioAtla, Inc. | 21.97M | -5.43% | 1,326,584 | 11.00M |
| 492 | PTIX | Protagenic Therapeutics, Inc. | 21.34M | -0.57% | 140,784 | - |
| 493 | DARE | Daré Bioscience, Inc. | 21.24M | - | 10,220 | 25.91K |
| 494 | RLMD | Relmada Therapeutics, Inc. | 20.91M | 4.81% | 297,692 | - |
| 495 | SLGL | Sol-Gel Technologies Ltd. | 20.61M | -0.94% | - | 12.10M |
| 496 | APUS | Apimeds Pharmaceuticals US, Inc. | 20.61M | 2.30% | 15,457 | - |
| 497 | CASI | CASI Pharmaceuticals, Inc. | 20.14M | -2.26% | 12,568 | 31.37M |
| 498 | BCTX | BriaCell Therapeutics Corp. | 20.03M | -0.68% | 69,779 | - |
| 499 | BLRX | BioLineRx Ltd. | 19.94M | -2.60% | 36,037 | 22.34M |
| 500 | LGVN | Longeveron Inc. | 19.66M | 0.77% | 41,898 | 2.23M |
| 501 | LSB | LakeShore Biopharma Co., Ltd | 18.99M | -2.44% | - | 79.42M |
| 502 | CRIS | Curis, Inc. | 18.94M | 3.43% | 131,472 | 11.20M |
| 503 | CING | Cingulate Inc. | 18.17M | -1.38% | 40,436 | - |
| 504 | MRKR | Marker Therapeutics, Inc. | 18.10M | 1.91% | 33,364 | 5.70M |
| 505 | MEIP | MEI Pharma, Inc. | 17.86M | 11.67% | 53,769 | - |
| 506 | BIVI | BioVie Inc. | 17.80M | -1.07% | 122,441 | - |
| 507 | QTTB | Q32 Bio Inc. | 17.56M | - | 52,785 | - |
| 508 | LEXX | Lexaria Bioscience Corp. | 17.54M | 5.24% | 31,059 | 525.92K |
| 509 | CARM | Carisma Therapeutics, Inc. | 16.84M | -4.05% | 398,572 | 19.96M |
| 510 | IMNN | Imunon, Inc. | 16.83M | -1.24% | 474,293 | - |
| 511 | LPCN | Lipocine Inc. | 16.59M | -0.32% | 25,672 | 3.67M |
| 512 | HOTH | Hoth Therapeutics, Inc. | 15.98M | 0.83% | 132,867 | - |
| 513 | SABS | SAB Biotherapeutics, Inc. | 15.98M | -1.71% | 14,060 | 377.84K |
| 514 | CLGN | CollPlant Biotechnologies Ltd. | 15.85M | -2.54% | 17,946 | 2.47M |
| 515 | HOOK | HOOKIPA Pharma Inc. | 15.59M | - | 13,904 | 9.35M |
| 516 | COCP | Cocrystal Pharma, Inc. | 15.46M | 0.66% | 14,097 | - |
| 517 | ALLR | Allarity Therapeutics, Inc. | 15.23M | 1.00% | 88,568 | - |
| 518 | PSTV | Plus Therapeutics, Inc. | 15.12M | -3.52% | 4,143,408 | 5.21M |
| 519 | EVAX | Evaxion A/S | 15.10M | -3.24% | 43,144 | 3.29M |
| 520 | ERNA | Ernexa Therapeutics Inc. | 14.72M | 1.01% | 29,398 | 535.00K |
| 521 | EDSA | Edesa Biotech, Inc. | 14.61M | 1.96% | 2,668 | - |
| 522 | LYRA | Lyra Therapeutics, Inc. | 14.39M | -3.33% | 43,427 | 1.19M |
| 523 | CANF | Can-Fite BioPharma Ltd. | 14.33M | -0.97% | 67,857 | 674.00K |
| 524 | ASBP | Aspire Biopharma Holdings, Inc. | 14.28M | 2.38% | 607,517 | - |
| 525 | PMN | ProMIS Neurosciences, Inc. | 14.13M | -3.50% | 171,284 | - |
| 526 | RLYB | Rallybio Corporation | 13.84M | 3.03% | 54,921 | 848.00K |
| 527 | SYBX | Synlogic, Inc. | 13.80M | -1.67% | 18,827 | 8.00K |
| 528 | NEUP | Neuphoria Therapeutics Inc. | 13.40M | 1.57% | 15,121 | 15.66M |
| 529 | ATHA | Athira Pharma, Inc. | 13.27M | 12.92% | 320,320 | - |
| 530 | PRTG | Portage Biotech Inc. | 12.90M | -3.08% | 10,418 | - |
| 531 | CVM | CEL-SCI Corporation | 12.79M | -1.19% | 192,158 | - |
| 532 | MTVA | MetaVia Inc. | 12.69M | -2.10% | 48,533 | - |
| 533 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 12.41M | -5.54% | 6,170,470 | 1.00M |
| 534 | NXTC | NextCure, Inc. | 12.22M | 1.75% | 86,057 | - |
| 535 | LPTX | Leap Therapeutics, Inc. | 12.08M | 1.18% | 292,332 | - |
| 536 | IBIO | iBio, Inc. | 12.02M | 0.14% | 697,852 | 375.00K |
| 537 | EVGN | Evogene Ltd. | 11.88M | -1.47% | 44,776 | 6.77M |
| 538 | TAOX | TAO Synergies Inc. | 11.81M | 5.20% | 140,000 | - |
| 539 | BTAI | BioXcel Therapeutics, Inc. | 11.69M | - | 78,607 | 1.85M |
| 540 | BRTX | BioRestorative Therapies, Inc. | 11.63M | -2.52% | 43,517 | 391.00K |
| 541 | NERV | Minerva Neurosciences, Inc. | 11.54M | -4.62% | 3,539 | - |
| 542 | PHGE | BiomX Inc. | 11.52M | - | 116,986 | - |
| 543 | PHIO | Phio Pharmaceuticals Corp. | 11.52M | -3.23% | 84,015 | - |
| 544 | EQ | Equillium, Inc. | 11.47M | 0.78% | 40,145 | 30.41M |
| 545 | ABP | Abpro Holdings, Inc. | 11.43M | -2.49% | 1,591,587 | 183.00K |
| 546 | SNSE | Sensei Biotherapeutics, Inc. | 11.38M | -2.59% | 5,809 | - |
| 547 | BOLT | Bolt Biotherapeutics, Inc. | 11.35M | 0.17% | 908 | 3.64M |
| 548 | ACXP | Acurx Pharmaceuticals, Inc. | 11.32M | -0.97% | 560,510 | - |
| 549 | APVO | Aptevo Therapeutics Inc. | 11.27M | - | 127,617 | - |
| 550 | BCDA | BioCardia, Inc. | 10.98M | 1.73% | 3,037,617 | 3.00K |
| 551 | KAPA | Kairos Pharma, Ltd. | 10.97M | -6.33% | 188,555 | - |
| 552 | XFOR | X4 Pharmaceuticals, Inc. | 10.94M | -4.55% | 380,088 | 31.36M |
| 553 | CSCI | COSCIENS Biopharma Inc. | 10.90M | 1.47% | - | 9.03M |
| 554 | XTLB | XTL Biopharmaceuticals Ltd. | 10.83M | 10.00% | 43,805 | 451.00K |
| 555 | CYCN | Cyclerion Therapeutics, Inc. | 10.79M | 1.82% | 19,378 | 2.08M |
| 556 | PTHS | Pelthos Therapeutics Inc. | 10.68M | -1.91% | 13,513 | - |
| 557 | TCRT | Alaunos Therapeutics, Inc. | 9.89M | -1.19% | 11,526 | 11.00K |
| 558 | IMRN | Immuron Limited | 9.84M | 4.41% | 15,595 | 4.05M |
| 559 | APRE | Aprea Therapeutics, Inc. | 9.62M | 2.35% | 9,114 | 1.28M |
| 560 | AEON | AEON Biopharma, Inc. | 9.47M | -0.29% | 234,826 | - |
| 561 | BCLI | Brainstorm Cell Therapeutics Inc. | 9.21M | -0.85% | 97,928 | - |
| 562 | DWTX | Dogwood Therapeutics, Inc. | 9.17M | -0.62% | 12,717 | - |
| 563 | ICU | SeaStar Medical Holding Corporation | 8.94M | -1.11% | 2,881,058 | 428.00K |
| 564 | GTBP | GT Biopharma, Inc. | 8.80M | -9.72% | 126,196 | - |
| 565 | CLRB | Cellectar Biosciences, Inc. | 8.70M | 1.48% | 238,704 | - |
| 566 | KPRX | Kiora Pharmaceuticals, Inc. | 8.67M | -0.35% | 14,406 | 20.00K |
| 567 | TSBX | Turnstone Biologics Corp. | 8.37M | 0.47% | 41,587 | - |
| 568 | CLDI | Calidi Biotherapeutics, Inc. | 8.26M | 5.09% | 551,055 | - |
| 569 | MBRX | Moleculin Biotech, Inc. | 8.19M | -2.16% | 1,255,133 | - |
| 570 | TRAW | Traws Pharma, Inc. | 8.07M | -0.68% | 56,964 | 227.00K |
| 571 | IBO | Impact BioMedical Inc. | 7.89M | -3.17% | 433,775 | - |
| 572 | LIXT | Lixte Biotechnology Holdings, Inc. | 7.80M | 40.10% | 64,110,102 | - |
| 573 | NLSP | NLS Pharmaceutics AG | 7.71M | -5.06% | 110,182 | - |
| 574 | PMCB | PharmaCyte Biotech, Inc. | 7.62M | -2.63% | 4,487 | - |
| 575 | GNPX | Genprex, Inc. | 7.55M | -3.59% | 555,704 | - |
| 576 | KZIA | Kazia Therapeutics Limited | 7.55M | 2.58% | 294,112 | 1.55M |
| 577 | INAB | IN8bio, Inc. | 7.51M | 0.93% | 98,996 | - |
| 578 | ADXN | Addex Therapeutics Ltd | 7.42M | 2.68% | 28,993 | 278.51K |
| 579 | INTS | Intensity Therapeutics, Inc. | 7.40M | -1.63% | 1,233,013 | - |
| 580 | PPBT | Purple Biotech Ltd | 7.15M | 3.33% | 5,817 | - |
| 581 | HCWB | HCW Biologics Inc. | 7.07M | -2.64% | 21,810 | 1.45M |
| 582 | RNAZ | TransCode Therapeutics, Inc. | 7.04M | 1.93% | 13,276 | - |
| 583 | CELZ | Creative Medical Technology Holdings, Inc. | 6.89M | - | 12,219 | 14.00K |
| 584 | APM | Aptorum Group Limited | 6.86M | 4.18% | 15,263 | - |
| 585 | SLXN | Silexion Therapeutics Corp | 6.82M | 0.70% | 107,001 | - |
| 586 | APLM | Apollomics, Inc. | 6.77M | -6.40% | 34,939 | 198.00K |
| 587 | GOVX | GeoVax Labs, Inc. | 6.64M | 0.69% | 1,187,530 | 5.59M |
| 588 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.61M | 3.26% | 29,262 | 19.90K |
| 589 | INDP | Indaptus Therapeutics, Inc. | 6.35M | 2.78% | 6,686 | - |
| 590 | XBIO | Xenetic Biosciences, Inc. | 5.71M | -6.09% | 40,890 | 2.58M |
| 591 | CMND | Clearmind Medicine Inc. | 5.65M | 21.82% | 41,810,093 | - |
| 592 | CYCC | Cyclacel Pharmaceuticals, Inc. | 5.61M | -4.80% | 2,592,071 | 14.00K |
| 593 | ARTL | Artelo Biosciences, Inc. | 5.49M | -8.88% | 91,217 | - |
| 594 | KTTA | Pasithea Therapeutics Corp. | 5.45M | -2.09% | 67,101 | - |
| 595 | MBIO | Mustang Bio, Inc. | 5.21M | -4.03% | 639,446 | - |
| 596 | TTNP | Titan Pharmaceuticals, Inc. | 5.19M | 1.15% | 18,730 | - |
| 597 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.18M | -4.24% | 2,795 | - |
| 598 | QLGN | Qualigen Therapeutics, Inc. | 5.17M | -3.19% | 4,783 | - |
| 599 | ADIL | Adial Pharmaceuticals, Inc. | 5.16M | -0.97% | 1,290,654 | - |
| 600 | PCSA | Processa Pharmaceuticals, Inc. | 5.10M | 3.34% | 2,849,854 | - |
| 601 | UBX | Unity Biotechnology, Inc. | 5.04M | -1.71% | 1,167,061 | - |
| 602 | CNSP | CNS Pharmaceuticals, Inc. | 5.02M | -2.12% | 71,025 | - |
| 603 | ATNF | 180 Life Sciences Corp. | 5.02M | -1.93% | 33,890 | - |
| 604 | THAR | Tharimmune, Inc. | 4.95M | 2.20% | 12,461 | - |
| 605 | GLTO | Galecto, Inc. | 4.68M | - | 2,225 | - |
| 606 | MTNB | Matinas BioPharma Holdings, Inc. | 4.67M | -2.43% | 14,981 | - |
| 607 | SILO | Silo Pharma, Inc. | 4.44M | -2.15% | 341,957 | 72.10K |
| 608 | AZTR | Azitra, Inc. | 4.32M | -1.45% | 289,897 | 7.50K |
| 609 | DRMA | Dermata Therapeutics, Inc. | 4.24M | -0.45% | 42,072 | - |
| 610 | GLMD | Galmed Pharmaceuticals Ltd. | 4.12M | 0.83% | 110,435 | - |
| 611 | VIVS | VivoSim Labs, Inc. | 4.08M | 2.61% | 11,911 | 144.00K |
| 612 | TOVX | Theriva Biologics, Inc. | 4.01M | -1.56% | 64,877 | - |
| 613 | SNGX | Soligenix, Inc. | 3.92M | -4.76% | 290,977 | 2.34K |
| 614 | ENSC | Ensysce Biosciences, Inc. | 3.80M | 1.76% | 9,664 | 6.22M |
| 615 | PLRZ | Polyrizon Ltd. | 3.75M | -2.18% | 172,131 | - |
| 616 | VRAX | Virax Biolabs Group Limited | 3.69M | -1.15% | 8,750 | 6.33K |
| 617 | NBY | NovaBay Pharmaceuticals, Inc. | 3.66M | 0.62% | 8,792 | 9.78M |
| 618 | CERO | CERo Therapeutics Holdings, Inc. | 3.58M | -2.11% | 56,322 | - |
| 619 | SPRC | SciSparc Ltd. | 3.53M | 1.23% | 123,220 | 1.31M |
| 620 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.51M | -3.25% | 9,775 | 802.32K |
| 621 | PALI | Palisade Bio, Inc. | 3.48M | -0.62% | 27,836 | - |
| 622 | JAGX | Jaguar Health, Inc. | 3.42M | 0.39% | 17,887 | 11.55M |
| 623 | XRTX | XORTX Therapeutics Inc. | 3.41M | -9.99% | 3,499,741 | - |
| 624 | WINT | Windtree Therapeutics, Inc. | 3.40M | 20.68% | 81,546,269 | - |
| 625 | GRI | GRI Bio, Inc. | 3.38M | -0.69% | 80,307 | - |
| 626 | ZVSA | ZyVersa Therapeutics, Inc. | 3.20M | -4.29% | 133,121 | - |
| 627 | ENVB | Enveric Biosciences, Inc. | 3.11M | 0.80% | 35,536 | - |
| 628 | ELAB | PMGC Holdings Inc. | 3.08M | -3.03% | 56,714 | 2.45M |
| 629 | CDT | Conduit Pharmaceuticals Inc. | 2.78M | 4.29% | 164,238 | - |
| 630 | ADTX | Aditxt, Inc. | 2.61M | -1.60% | 336,777 | 55.32K |
| 631 | BDRX | Biodexa Pharmaceuticals Plc | 2.48M | -2.43% | 77,527 | 104.90K |
| 632 | ONCO | Onconetix, Inc. | 2.43M | -4.12% | 63,819 | 1.93M |
| 633 | ALZN | Alzamend Neuro, Inc. | 2.16M | -2.00% | 89,123 | - |
| 634 | SCNI | Scinai Immunotherapeutics Ltd. | 2.06M | -2.95% | 73,235 | 658.00K |
| 635 | ENTO | Entero Therapeutics, Inc. | 1.92M | -0.54% | 68,057 | - |
| 636 | SLRX | Salarius Pharmaceuticals, Inc. | 1.89M | -1.17% | 45,551 | - |
| 637 | TNFA | TNF Pharmaceuticals, Inc. | 1.68M | 2.07% | 3,407,294 | - |
| 638 | REVB | Revelation Biosciences, Inc. | 1.54M | -1.31% | 367,593 | - |
| 639 | OGEN | Oragenics, Inc. | 1.26M | 6.25% | 2,000,636 | - |
| 640 | NCNA | NuCana plc | 324.65K | -5.13% | 43,427,988 | - |